Schonfeld Strategic Advisors’s Regenxbio RGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-124,632
| Closed | -$1.31M | – | 2186 |
|
|
2024
Q3 | $1.31M | Buy |
124,632
+75,512
| +154% | +$792K | 0.01% | 937 |
|
|
2024
Q2 | $575K | Sell |
49,120
-134,675
| -73% | -$1.58M | ﹤0.01% | 1303 |
|
|
2024
Q1 | $3.87M | Buy |
+183,795
| New | +$3.87M | 0.03% | 613 |
|
|
2022
Q4 | – | Sell |
-7,578
| Closed | -$200K | – | 2831 |
|
|
2022
Q3 | $200K | Buy |
+7,578
| New | +$200K | ﹤0.01% | 2295 |
|
|
2019
Q4 | – | Sell |
-10,900
| Closed | -$387K | – | 1435 |
|
|
2019
Q3 | $387K | Sell |
10,900
-31,400
| -74% | -$1.11M | 0.01% | 718 |
|
|
2019
Q2 | $2.17M | Sell |
42,300
-46,800
| -53% | -$2.4M | 0.08% | 275 |
|
|
2019
Q1 | $5.11M | Buy |
+89,100
| New | +$5.11M | 0.18% | 155 |
|
|
2018
Q4 | – | Sell |
-25,700
| Closed | -$1.94M | – | 1201 |
|
|
2018
Q3 | $1.94M | Sell |
25,700
-84,200
| -77% | -$6.36M | 0.09% | 288 |
|
|
2018
Q2 | $7.89M | Buy |
109,900
+59,900
| +120% | +$4.3M | 0.43% | 52 |
|
|
2018
Q1 | $1.49M | Sell |
50,000
-108,687
| -68% | -$3.25M | 0.11% | 249 |
|
|
2017
Q4 | $5.28M | Buy |
158,687
+18,567
| +13% | +$617K | 0.43% | 62 |
|
|
2017
Q3 | $4.62M | Buy |
140,120
+65,120
| +87% | +$2.15M | 0.42% | 72 |
|
|
2017
Q2 | $1.48M | Sell |
75,000
-1,911
| -2% | -$37.7K | 0.15% | 199 |
|
|
2017
Q1 | $1.49M | Buy |
76,911
+36,911
| +92% | +$713K | 0.15% | 192 |
|
|
2016
Q4 | $742K | Buy |
+40,000
| New | +$742K | 0.1% | 270 |
|